Ozge Basaran
Overview
Explore the profile of Ozge Basaran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sener S, Batu E, Basaran O, Balik Z, Aliyev E, Bayindir Y, et al.
Turk J Pediatr
. 2025 Mar;
67(1):61-68.
PMID: 40084723
Objective: We aimed to identify and compare systemic juvenile idiopathic arthritis (sJIA) patients receiving treatment with either glucocorticoids and/or conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) or biologic drugs. Methods: This...
2.
Gezgin Yildirim D, Orulluoglu E, Yildiz C, Acari C, Dundar H, Akaci O, et al.
Pediatr Rheumatol Online J
. 2025 Mar;
23(1):24.
PMID: 40069880
Background: Cyclophosphamide (CYC) is an inactive alkylating agent that transforms the alkyl radicals into other molecules and is used in combination with systemic corticosteroids in the treatment of many childhood...
3.
Zhao Y, Oliver M, Schnabel A, Wu E, Wang Z, Marino A, et al.
Ann Rheum Dis
. 2025 Feb;
PMID: 39966038
The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the article will be...
4.
Basaran O, Sag E, Arslanoglu Aydin E, Aydin B, Tasdemir N, Celikel E, et al.
Pediatr Rheumatol Online J
. 2025 Feb;
23(1):14.
PMID: 39923056
Background: Macrophage activation syndrome (MAS) is a severe complication of systemic juvenile idiopathic arthritis (sJIA), driven by excessive activation of T cells and macrophages, resulting in a cytokine storm. IFN-γ...
5.
Sener S, Batu E, Aliyev E, Basaran O, Saribas Z, Bilginer Y, et al.
Mod Rheumatol
. 2025 Feb;
PMID: 39901832
Objective: The importance of antinuclear antibodies (ANA) patterns and titers in juvenile idiopathic arthritis (JIA) patients is not clearly determined in the literature. In our study, we evaluated the ANA...
6.
Sener S, Unal D, Batu E, Kart Bayram G, Firlatan B, Kilic L, et al.
Int J Rheum Dis
. 2025 Jan;
28(1):e70082.
PMID: 39835506
Aim: In this study, we aimed to evaluate and compare the characteristics of pediatric and adult rhupus patients. Methods: Thirty pediatric patients with rhupus syndrome and 15 adult patients with...
7.
Sener S, Yardimci G, Batu E, Kilic L, Kaya Akca U, Kasap Cuceoglu M, et al.
Turk J Med Sci
. 2024 Dec;
54(6):1198-1204.
PMID: 39734331
Background/aim: The transition from pediatric to adult-oriented care for individuals with juvenile-onset systemic lupus erythematosus (SLE) poses significant challenges. This study aimed to assess the outcomes of transitioning patients with...
8.
Sener S, Sener Y, Batu E, Ertugrul I, Basaran O, Bilginer Y, et al.
Expert Rev Cardiovasc Ther
. 2024 Dec;
:1-5.
PMID: 39699079
Background: This study aimed to evaluate the effects of hydroxychloroquine on cardiac functions and left ventricular mass in patients with childhood-onset systemic lupus erythematosus (cSLE). Research Design And Methods: Fifty...
9.
Sener S, Batu E, Unal D, Basaran O, Saribas Z, Bilginer Y, et al.
Lupus
. 2024 Nov;
34(1):71-78.
PMID: 39603714
Objective: Antinuclear antibodies (ANA) staining patterns can provide useful information in systemic lupus erythematosus (SLE). In our study, we examined the frequency of ANA staining patterns in disease-related features in...
10.
Ayan G, Basaran O, Firlatan B, Kilic L, Bilginer Y, Alikasifoglu M, et al.
Int J Rheum Dis
. 2024 Nov;
27(11):e15377.
PMID: 39558610
Background/purpose: Our objective was to investigate real-world outcomes and treatment strategies in individuals affected by DADA2 using over 10-year period real-life experience. Methods: This descriptive analysis encompassed all adult/pediatric patients...